Showing results (631-640 of 809) with videos related to
Sort By:
Pageof 81
Epilepsy & Behavior : E&B|August 17, 2014
Providers' perspectives on treating psychogenic nonepileptic seizures: frustration and hopeKatharine K McMillan, Mary Jo Pugh, Hamada Hamid, et al.Safety Science|May 31, 2016
Danger zone: Men, masculinity and occupational health and safety in high risk occupationsMary Stergiou-Kita, Elizabeth Mansfield, Randy Bezo, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2017
Cingulo-insular structural alterations associated with psychogenic symptoms, childhood abuse and PTSD in functional neurological disordersDavid L Perez, Nassim Matin, Arthur Barsky, et al.The Journal of Orthopaedic and Sports Physical Therapy|September 24, 2025
Efficacy of Therapeutic Patient Education for Managing Subacute and Chronic Musculoskeletal Conditions: A Systematic Review With Meta-AnalysisAudrey-Anne Cormier, François Desmeules, Frédérique Dupuis, et al.Epilepsy & Behavior Reports|December 8, 2021
The role of evidence-based guidelines in the diagnosis and treatment of functional neurological disorderBenjamin Tolchin, Gaston Baslet, Alan Carson, et al.Nature Ecology & Evolution|April 30, 2021
Migratory strategy drives species-level variation in bird sensitivity to vegetation green-upCasey Youngflesh, Jacob Socolar, Bruna R Amaral, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2015
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKDLaurence Lepage, Anne-Claude Dufour, Jessica Doiron, et al.Epilepsy & Behavior : E&B|April 21, 2017
Risk factors for learning problems in youth with psychogenic non-epileptic seizuresJulia Doss, Rochelle Caplan, Prabha Siddarth, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|April 2, 2019
Providing Quality Epilepsy Care for Veterans, Hamada Altalib, Jose Cavazos, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2025
Asymmetric synthesis of potent and orally bioavailable thiophene-based EZH2 inhibitorsXinrong Tian, Ken Newlander, Louis LaFrance, et al.Pageof 81